Clinical and Molecular Features of Epidermal Growth Factor Receptor (EGFR) Mutation Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors (TKIs): Predictive and Prognostic Role of Co-Mutations.
Paolo BironzoMaria Lucia RealeTessa SperoneFabrizio TabbòAndrea CaglioAngela ListìFrancesco PassigliaMassimo Di MaioLuisella RighiFederico BussolinoGiorgio Vittorio ScagliottiSilvia NovelloPublished in: Cancers (2021)
Pathogenic co-alterations does not seem to predict survival nor efficacy of EGFR TKIs in previously untreated advanced NSCLC.